These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1190 related items for PubMed ID: 21875904

  • 1. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice.
    Cheang WS, Wong WT, Tian XY, Yang Q, Lee HK, He GW, Yao X, Huang Y.
    Cardiovasc Res; 2011 Nov 01; 92(2):267-75. PubMed ID: 21875904
    [Abstract] [Full Text] [Related]

  • 2. Ramipril improves oxidative stress-related vascular endothelial dysfunction in db/db mice.
    Liang W, Tan CY, Ang L, Sallam N, Granville DJ, Wright JM, Laher I.
    J Physiol Sci; 2008 Dec 01; 58(6):405-11. PubMed ID: 18845058
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of bone morphogenic protein 4 restores endothelial function in db/db diabetic mice.
    Zhang Y, Liu J, Tian XY, Wong WT, Chen Y, Wang L, Luo J, Cheang WS, Lau CW, Kwan KM, Wang N, Yao X, Huang Y.
    Arterioscler Thromb Vasc Biol; 2014 Jan 01; 34(1):152-9. PubMed ID: 24202302
    [Abstract] [Full Text] [Related]

  • 4. Endothelial nitric oxide synthase enhancer for protection of endothelial function from asymmetric dimethylarginine-induced injury in human internal thoracic artery.
    Xuan C, Chang FJ, Liu XC, Bai XY, Liao XL, He GW, Ou JS.
    J Thorac Cardiovasc Surg; 2012 Sep 01; 144(3):697-703. PubMed ID: 22336756
    [Abstract] [Full Text] [Related]

  • 5. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Wohlfart P, Xu H, Endlich A, Habermeier A, Closs EI, Hübschle T, Mang C, Strobel H, Suzuki T, Kleinert H, Förstermann U, Ruetten H, Li H.
    J Pharmacol Exp Ther; 2008 May 01; 325(2):370-9. PubMed ID: 18252813
    [Abstract] [Full Text] [Related]

  • 6. Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase.
    Yuen CY, Wong WT, Tian XY, Wong SL, Lau CW, Yu J, Tomlinson B, Yao X, Huang Y.
    Cardiovasc Res; 2011 Apr 01; 90(1):122-9. PubMed ID: 21156825
    [Abstract] [Full Text] [Related]

  • 7. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F.
    Eur J Pharmacol; 2005 Mar 21; 511(1):53-64. PubMed ID: 15777779
    [Abstract] [Full Text] [Related]

  • 8. Endothelial nitric oxide synthase enhancer AVE3085 reverses endothelial dysfunction induced by homocysteine in human internal mammary arteries.
    Hou HT, Wang J, Zhang X, Wang ZQ, Chen TN, Zhang JL, Yang Q, He GW.
    Nitric Oxide; 2018 Dec 01; 81():21-27. PubMed ID: 30300735
    [Abstract] [Full Text] [Related]

  • 9. AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats.
    Yang Q, Xue HM, Wong WT, Tian XY, Huang Y, Tsui SK, Ng PK, Wohlfart P, Li H, Xia N, Tobias S, Underwood MJ, He GW.
    Br J Pharmacol; 2011 Jul 01; 163(5):1078-85. PubMed ID: 21385179
    [Abstract] [Full Text] [Related]

  • 10. AVE3085 protects coronary endothelium from the impairment of asymmetric dimethylarginine by activation and recoupling of eNOS.
    Xue HM, Yu CM, Underwood MJ, Huang JH, Yang Q.
    Cardiovasc Drugs Ther; 2012 Oct 01; 26(5):383-92. PubMed ID: 22890813
    [Abstract] [Full Text] [Related]

  • 11. Uncoupling protein-2 protects endothelial function in diet-induced obese mice.
    Tian XY, Wong WT, Xu A, Lu Y, Zhang Y, Wang L, Cheang WS, Wang Y, Yao X, Huang Y.
    Circ Res; 2012 Apr 27; 110(9):1211-6. PubMed ID: 22461387
    [Abstract] [Full Text] [Related]

  • 12. Lycopene attenuates endothelial dysfunction in streptozotocin-induced diabetic rats by reducing oxidative stress.
    Zhu J, Wang CG, Xu YG.
    Pharm Biol; 2011 Nov 27; 49(11):1144-9. PubMed ID: 21517710
    [Abstract] [Full Text] [Related]

  • 13. Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4.
    Liang CF, Liu JT, Wang Y, Xu A, Vanhoutte PM.
    Arterioscler Thromb Vasc Biol; 2013 Apr 27; 33(4):777-84. PubMed ID: 23413427
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II type 2 receptor-dependent increase in nitric oxide synthase activity in the endothelium of db/db mice is mediated via a MEK pathway.
    Taguchi K, Matsumoto T, Kamata K, Kobayashi T.
    Pharmacol Res; 2012 Jul 27; 66(1):41-50. PubMed ID: 22465219
    [Abstract] [Full Text] [Related]

  • 15. Endothelial nitric oxide synthase activation leads to dilatory H2O2 production in mouse cerebral arteries.
    Drouin A, Thorin-Trescases N, Hamel E, Falck JR, Thorin E.
    Cardiovasc Res; 2007 Jan 01; 73(1):73-81. PubMed ID: 17113574
    [Abstract] [Full Text] [Related]

  • 16. Essential role of bone marrow for microvascular endothelial and metabolic functions in mice.
    Nakajima S, Ohashi J, Sawada A, Noda K, Fukumoto Y, Shimokawa H.
    Circ Res; 2012 Jun 22; 111(1):87-96. PubMed ID: 22550140
    [Abstract] [Full Text] [Related]

  • 17. A nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist reverses endothelial dysfunction in diabetic (db/db-/-) mice.
    Howarth AG, Wiehler WB, Pannirselvam M, Jiang Y, Berger JP, Severson D, Anderson TJ, Triggle CR.
    J Pharmacol Exp Ther; 2006 Jan 22; 316(1):364-70. PubMed ID: 16249369
    [Abstract] [Full Text] [Related]

  • 18. Propofol protects against high glucose-induced endothelial dysfunction in human umbilical vein endothelial cells.
    Zhu M, Chen J, Tan Z, Wang J.
    Anesth Analg; 2012 Feb 22; 114(2):303-9. PubMed ID: 22156331
    [Abstract] [Full Text] [Related]

  • 19. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow.
    Belin de Chantemèle EJ, Vessières E, Guihot AL, Toutain B, Maquignau M, Loufrani L, Henrion D.
    Cardiovasc Res; 2009 Mar 01; 81(4):788-96. PubMed ID: 19050009
    [Abstract] [Full Text] [Related]

  • 20. Mechanistic studies of AVE3085 against homocysteine in endothelial protection.
    Yang Q, Xue HM, Underwood MJ, Yu CM.
    Cardiovasc Drugs Ther; 2013 Dec 01; 27(6):511-20. PubMed ID: 23846330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.